---
title: "Allakos (ALLK.US) — 公司概況"
type: "Symbol"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/quote/ALLK.US/overview.md"
symbol: "ALLK.US"
name: "Allakos"
parent: "https://longbridge.com/zh-HK/quote/ALLK.US.md"
datetime: "2026-04-05T08:09:35.589Z"
locales:
  - [en](https://longbridge.com/en/quote/ALLK.US/overview.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/ALLK.US/overview.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/ALLK.US/overview.md)
---

> 支持的語言: [English](https://longbridge.com/en/quote/ALLK.US/overview.md) | [简体中文](https://longbridge.com/zh-CN/quote/ALLK.US/overview.md)


# Allakos (ALLK.US) — 公司概況

## 基本資訊

| 項目 | 詳情 |
|------|--------|
| 行業 | Biotechnology |
| 交易所 | US Market |

## 公司簡介

Allakos Inc., a clinical stage biotechnology company, engages in the development of therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases in the United States. The company was incorporated in 2012 and is headquartered in San Carlos, California.


---

> **免責聲明: 本文僅供參考，不構成任何投資建議。**